Protein A Immunoadsorption Relieves Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy after Unsuccessful Methylprednisolone Treatment
暂无分享,去创建一个
Yuge Wang | W. Qiu | Xiaobo Sun | Y. Shu | B. Qin | Ruizhen Wu | Boguang Yu
[1] D. Deng,et al. Meta-analysis on the efficacy and safety of immunoadsorption for systemic lupus erythematosus among Chinese population , 2020, Clinical Rheumatology.
[2] Yong-Beom Park,et al. Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis , 2020, BMC Pulmonary Medicine.
[3] S. Tzartos,et al. Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis , 2019, Journal of Neuroimmunology.
[4] J. Dreyhaupt,et al. Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial , 2019, EClinicalMedicine.
[5] W. Rottbauer,et al. Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy , 2019, Biomolecules.
[6] Honghao Wang,et al. Elevated Levels of NLRP3 in Cerebrospinal Fluid of Patients With Autoimmune GFAP Astrocytopathy , 2019, Front. Neurol..
[7] Y. Hayashi,et al. Cytokines and biological markers in autoimmune GFAP astrocytopathy: The potential role for pathogenesis and therapeutic implications , 2019, Journal of Neuroimmunology.
[8] Y. Hayashi,et al. Clinical characteristics of autoimmune GFAP astrocytopathy , 2019, Journal of Neuroimmunology.
[9] Y. Long,et al. Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack. , 2019, Multiple sclerosis and related disorders.
[10] Yingying Su,et al. Efficacy of Therapeutic Plasma Exchange in Patients with Severe Refractory Anti-NMDA Receptor Encephalitis , 2019, Neurotherapeutics.
[11] A. McKeon,et al. Autoimmune glial fibrillary acidic protein astrocytopathy , 2019, Current opinion in neurology.
[12] Y. Long,et al. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature , 2018, Front. Immunol..
[13] B. Weinshenker,et al. Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[14] Y. Long,et al. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study , 2018, European journal of neurology.
[15] A. McKeon,et al. A path to understanding autoimmune GFAP astrocytopathy , 2018, European journal of neurology.
[16] W. Köhler,et al. Immunoadsorption for autoimmune encephalitis. , 2017, Atherosclerosis. Supplements.
[17] E. Hol,et al. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[18] Y. Long,et al. Treatment of Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: Follow-Up in 7 Cases , 2017, Neuroimmunomodulation.
[19] B. Weinshenker,et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients , 2017, Annals of neurology.
[20] V. Lennon,et al. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis. , 2016, JAMA neurology.
[21] B. Bonnekoh,et al. Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.